BioHistory Moment: Diamond v. Chakrabarty case argued before U.S. Supreme Court
On March 17, 1980, the Diamond v. Chakrabarty case was argued before the U.S. Supreme Court regarding the
patentability of genetically altered microorganisms.
In 1972, Chakrabarty filed a patent application assigned to the General Electric Co. for a human-made genetically
engineered bacterium capable of breaking down multiple components of crude oil. The application asserted 36 claims
related to Chakrabarty's invention of a bacterium from the genus Pseudomonas containing at least two
stable energy-generating plasmids, each of said plasmids providing a separate hydrocarbon degradative pathway.
On June 16, 1980, the U.S. Supreme Court upheld five-to-four the patentability of genetically altered organisms,
opening the door to greater patent protection for any modified life forms. Chief Justice Warren Burger
delivered the opinion of the Court, in which justices Potter Stewart, Harry Blackmun, William Rehnquist, and
John Paul Stevens joined. William Brennan filed the dissenting opinion, in which Byron White, Thurgood Marshall,
and Lewis Powell joined.
 More...
Learn about Seattle's Life Science Incubator Facility
Seattle's Life Science Incubator Research facility was commissioned in 1988, and is a contemporary-designed building provided with
modern research systems. Four floors are specifically laboratory space, one floor is a fully equipped vivarium and one floor is clinical
space and management offices. The faciility is centrally located in close proximity to downtown Seattle, the University of Washington,
the Fred Hutchinson Cancer Research Center, and more.
Learn about this and other biotechnology, medical device and pharmaceutical facilities available for sale,
lease or sublease in South Carolina, regionally or nationwide.
More...
(Advertising)
|
|
|
Industry News...
Free News Release Posting & Archiving Service
- U.S. Food And Drug Administration accepts New Drug Application Bristol-Myers Squibb and AstraZeneca announced that the FDA has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA(TM) (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets.
Bristol-Myers Squibb Company March 17, 2010
- Study shows Prevenar 13* is immunogenic in young children previously vaccinated According to results from a Phase III safety and immunogenicity study presented today, Prevenar 13* was shown to be immunogenic and generally well tolerated in healthy young children who had received at least three prior doses of Prevenar* (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed).
Pfizer Inc. March 17, 2010
- Star Scientific regains compliance with NASDAQ Star Scientific reported that after the close of trading on March 16 it received a letter from NASDAQ indicating that Star now has regained compliance with the NASDAQ minimum bid-price listing requirement.
Star Scientific, Inc. March 16, 2010
- Trimeris reports financial results for the fourth quarter and full year 2009 Trimeris reported net income of $7.2 million for the fourth quarter of 2009 compared with $1.5 million for the fourth quarter of 2008. Cash, cash equivalents and investment securities available-for-sale totaled $48.4 million at December 31, 2009, compared to $31.6 million at December 31, 2008.
Trimeris, Inc. March 16, 2010
- Boston Scientific completes enrollment in PLATINUM trials Boston Scientific announced completion of patient enrollment in the Small Vessel and Long Lesion trials of its PLATINUM clinical program that are designed to compare the platinum chromium PROMUS® Element Everolimus-Eluting Stent System to matched historical control groups of patients.
Boston Scientific Corporation March 16, 2010
More... | Submit News Release | Advertising...
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
 More... |
Submit Event |
Event Advertising...
|
|
Learn About South Carolina's BioHistory
Why is there a life science industry in South Carolina? Is the industry
growing? What do other states have?
Through South Carolina BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industry in South Carolina.
More...
BioEvolution Posters
More...
March - National Colorectal Cancer Awareness Month
As a leading health organization for 25 years, the Prevent Cancer Foundation, the vision of Carolyn Aldigé, has
catapulted cancer prevention to prominence and provided more than $113 million in support of cancer prevention
and early detection research, education and community outreach programs across the country.
More...
BioFact
(1926) - Henry Agard Wallace, Secretary of Agriculture during Franklin Roosevelt's first two terms and Vice President during his third, starts the Hi-Bred Company - a hybrid corn-seed producer and marketer known today as Pioneer Hi-Bred International, Inc.
It's a Small World
|
| |
Lactobacillus Bacteria
| |
Science Quote
"True science teaches, above all, to doubt and be ignorant."
| - |
Miguel de Unamuno, Spanish philosopher
|
|
(1864-1936)
|
|
